Holen Sie sich die Stockscreener-App
1.31
0.00%
0.00
Vorhandelsmarkt:
1.33
0.02
+1.53%
Schlusskurs vom Vortag:
$1.31
Offen:
$1.33
24-Stunden-Volumen:
712.84K
Relative Volume:
0.99
Marktkapitalisierung:
$59.90M
Einnahmen:
$19.94M
Nettoeinkommen (Verlust:
$-37.37M
KGV:
-1.2596
EPS:
-1.04
Netto-Cashflow:
$-33.38M
1W Leistung:
-22.49%
1M Leistung:
-36.10%
6M Leistung:
+44.80%
1J Leistung:
-47.18%
1-Tages-Spanne:
$1.24
$1.33
1-Wochen-Bereich:
$1.08
$1.72
52-Wochen-Spanne:
$0.595
$2.52
Werewolf Therapeutics Inc Stock (HOWL) Company Profile
Firmenname
Werewolf Therapeutics Inc
Sektor
Branche
Telefon
617-952-0555
Adresse
200 TALCOTT AVENUE, WATERTOWN
Vergleichen Sie HOWL mit anderen Aktien
| Aktien | Preis | Marktkapitalisierung | Umsatz | Nettogewinn | Free Cashflow | ENV |
|---|---|---|---|---|---|---|
HOWL
Werewolf Therapeutics Inc
|
1.31 | 59.90M | 19.94M | -37.37M | -33.38M | -1.04 |
|
VRTX
Vertex Pharmaceuticals Inc
|
426.00 | 109.11B | 11.39B | 3.64B | 3.50B | 13.99 |
|
REGN
Regeneron Pharmaceuticals Inc
|
642.25 | 68.50B | 14.25B | 4.58B | 3.88B | 41.77 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
434.07 | 60.25B | 3.21B | 43.57M | 221.36M | 0.2405 |
|
ARGX
Argen X Se Adr
|
826.28 | 50.39B | 3.06B | 1.28B | 447.35M | 19.67 |
|
INSM
Insmed Inc
|
186.23 | 40.44B | 447.02M | -1.18B | -868.57M | -6.1812 |
Werewolf Therapeutics Inc Stock (HOWL) Upgrades & Downgrades
| Datum | Aktion | Analytiker | Ratingänderung |
|---|---|---|---|
| 2024-04-03 | Eingeleitet | JMP Securities | Mkt Outperform |
| 2023-08-24 | Eingeleitet | Wedbush | Outperform |
| 2023-06-06 | Fortgesetzt | Jefferies | Buy |
| 2021-09-10 | Eingeleitet | BofA Securities | Buy |
| 2021-05-25 | Eingeleitet | Evercore ISI | Outperform |
| 2021-05-25 | Eingeleitet | H.C. Wainwright | Buy |
| 2021-05-25 | Eingeleitet | Jefferies | Buy |
| 2021-05-25 | Eingeleitet | SVB Leerink | Outperform |
Alle ansehen
Werewolf Therapeutics Inc Aktie (HOWL) Neueste Nachrichten
Werewolf Therapeutics Q3 net loss narrows on lower R&D expenses - MarketScreener
Werewolf Therapeutics Reports Third Quarter 2025 Financial Results and Provides Business Update - GlobeNewswire
Visual trend scoring systems applied to Werewolf Therapeutics Inc.July 2025 Decliners & Accurate Technical Buy Alerts - newser.com
Werewolf therapeutics director Evnin sells $251k in HOWL stock By Investing.com - Investing.com Canada
Werewolf therapeutics director Evnin sells $251k in HOWL stock - Investing.com
A History of Outperforming Analyst Forecasts and Beating the Odds: Werewolf Therapeutics Inc (HOWL) - setenews.com
Is Werewolf Therapeutics Inc. stock bottoming outJuly 2025 EndofMonth & Comprehensive Market Scan Insights - newser.com
How Werewolf Therapeutics Inc. stock performs after earnings2025 Market Sentiment & Fast Entry High Yield Tips - newser.com
What MACD signals say about Werewolf Therapeutics Inc.Global Markets & AI Driven Price Predictions - newser.com
Will Werewolf Therapeutics Inc. stock recover faster than marketQuarterly Trade Review & Verified Entry Point Detection - newser.com
Analyzing recovery setups for Werewolf Therapeutics Inc. investorsStock Surge & Long-Term Safe Investment Plans - newser.com
Advanced analytics toolkit walkthrough for Werewolf Therapeutics Inc.Portfolio Update Summary & Entry Point Strategy Guides - newser.com
Will Werewolf Therapeutics Inc. price bounce be sustainable2025 Top Decliners & Entry Point Confirmation Alerts - newser.com
How to read the order book for Werewolf Therapeutics Inc.July 2025 Closing Moves & High Return Stock Watch Alerts - newser.com
Will Werewolf Therapeutics Inc. stock outperform growth indexesWeekly Trade Analysis & Weekly High Conviction Ideas - newser.com
Werewolf Therapeutics Inc. stock trendline breakdownJuly 2025 Retail & Technical Pattern Alert System - newser.com
Identifying reversal signals in Werewolf Therapeutics Inc.Price Action & AI Driven Stock Movement Reports - newser.com
Predicting Werewolf Therapeutics Inc. trend using moving averagesEntry Point & Risk Managed Investment Signals - newser.com
Werewolf Therapeutics Inc expected to post a loss of 39 cents a shareEarnings Preview - TradingView
Werewolf Therapeutics (HOWL) Expected to Announce Quarterly Earnings on Thursday - MarketBeat
Is Werewolf Therapeutics Inc. reversing from oversold territoryBuy Signal & Expert Approved Trade Ideas - newser.com
Will Werewolf Therapeutics Inc. stock reach all time highs in 2025Weekly Profit Analysis & Weekly High Return Forecasts - newser.com
Werewolf Therapeutics (NASDAQ:HOWL) Major Shareholder Sells $113,271.52 in Stock - MarketBeat
Luke Evnin Sells 86,154 Shares of Werewolf Therapeutics (NASDAQ:HOWL) Stock - MarketBeat
Insider Selling: Werewolf Therapeutics (NASDAQ:HOWL) Major Shareholder Sells 69,068 Shares of Stock - MarketBeat
Why analysts remain bullish on Werewolf Therapeutics Inc. stockJuly 2025 Highlights & Reliable Volume Spike Alerts - fcp.pa.gov.br
Finanzdaten der Werewolf Therapeutics Inc-Aktie (HOWL)
Umsatz
Nettogewinn
Free Cashflow
ENV
0.64%
0.35%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):